The JAK-STAT pathway also interacts with p53 signaling in hematologic malignancies: JAK2 V617F promotes p53 degradation via murine double minute 2 (MDM2) and La protein through the PI3K/Akt/mTOR pathway, while STAT1 counters this by stabilizing p53. Here, STAT1 is linked to hematologic disorder.